Alexandria Forbes and Thomas Shenk are stepping down from the Kadmon Holdings Inc. board.
The directors are resigning to focus on their responsibilities at MeiraGTx Holdings PLC.
New York-based Kadmon Holdings is a biopharmaceutical company developing treatments for inflammatory and fibrotic diseases.
